These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12460032)

  • 21. Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism.
    Molad Y; Gal E; Magal N; Sulkes J; Mukamel M; Weinberger A; Lalazari S; Shohat M
    Semin Arthritis Rheum; 2000 Oct; 30(2):132-7. PubMed ID: 11071585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of beta-chemokines in systemic lupus erythematosus.
    Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
    J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional monocyte chemoattractant protein-1 promoter -2518 polymorphism and systemic lupus erythematosus: a meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2010 Oct; 37(7):3421-6. PubMed ID: 19941075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus.
    Prkacin I; Novak B; Sertić J; Mrzljak A
    Acta Med Croatica; 2001; 55(2):73-6. PubMed ID: 11505631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus.
    Johansson M; Arlestig L; Möller B; Rantapää-Dahlqvist S
    Arthritis Rheum; 2005 Jun; 52(6):1665-9. PubMed ID: 15934088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.
    Aguilar F; González-Escribano MF; Sánchez-Román J; Núñez-Roldán A
    Tissue Antigens; 2001 Nov; 58(5):335-8. PubMed ID: 11844145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
    Vincent FB; Kandane-Rathnayake R; Hoi AY; Slavin L; Godsell JD; Kitching AR; Harris J; Nelson CL; Jenkins AJ; Chrysostomou A; Hibbs ML; Kerr PG; Rischmueller M; Mackay F; Morand EF
    Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
    Dai C; Liu Z; Zhou H; Li L
    Chin Med J (Engl); 2001 Aug; 114(8):864-8. PubMed ID: 11780369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
    Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
    Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of hOGG1 C1245G polymorphism in the susceptibility to lupus nephritis and modulation of the plasma 8-OHdG in patients with systemic lupus erythematosus.
    Lee HT; Lin CS; Lee CS; Tsai CY; Wei YH
    Int J Mol Sci; 2015 Feb; 16(2):3757-68. PubMed ID: 25671815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
    Marks SD; Williams SJ; Tullus K; Sebire NJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus.
    Brown KS; Nackos E; Morthala S; Jensen LE; Whitehead AS; Von Feldt JM
    J Rheumatol; 2007 Apr; 34(4):740-6. PubMed ID: 17407231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
    Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A
    Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease.
    Nishimura M; Kuno S; Mizuta I; Ohta M; Maruyama H; Kaji R; Kawakami H
    Mov Disord; 2003 Aug; 18(8):953-5. PubMed ID: 12889089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
    Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
    Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
    Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
    Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus.
    Sánchez E; Sabio JM; Callejas JL; de Ramón E; Garcia-Portales R; García-Hernández FJ; Jiménez-Alonso J; González-Escribano MF; Martín J; Koeleman BP
    BMC Med Genet; 2006 May; 7():48. PubMed ID: 16719905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Li LH; Yuan H; Pan HF; Li WX; Li XP; Ye DQ
    Scand J Rheumatol; 2010 Mar; 39(2):148-54. PubMed ID: 20059375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.